Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration

被引：167
作者：
Kinnunen, Kati [1 ,2 ]
Petrovski, Goran [3 ,4 ]
Moe, Morten C. [5 ]
Berta, Andras [4 ]
Kaarniranta, Kai [1 ,2 ]
机构：
[1] Univ Eastern Finland, Dept Ophthalmol, Inst Clin Med, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland
[3] Univ Debrecen, Dept Biochem & Mol Biol, Apoptosis & Genom Res Grp, Hungarian Acad Sci, H-4012 Debrecen, Hungary
[4] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[5] Univ Oslo, Ctr Eye Res, Dept Ophthalmol, Oslo Univ Hosp, Oslo, Norway
来源：
ACTA OPHTHALMOLOGICA | 2012年 / 90卷 / 04期
关键词：
drusen; lipofuscin; macular degeneration; retinal pigment epithelium; ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR-H; FUNDUS AUTOFLUORESCENCE PATTERNS; ENDOPLASMIC-RETICULUM STRESS; HTRA1 PROMOTER POLYMORPHISM; GLYCATION END-PRODUCTS; BRUCHS MEMBRANE; APOLIPOPROTEIN-E; SEQUESTOSOME; 1/P62; VARIANT INCREASES;
D O I：
10.1111/j.1755-3768.2011.02179.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Age-related macular degeneration (AMD) is attributed to a complex interaction of genetic and environmental factors. It is characterized by degeneration involving the retinal photoreceptors, retinal pigment epithelium (RPE) and Bruch's membrane, as well as alterations in choroidal capillaries. AMD pathogenesis is strongly associated with chronic oxidative stress and inflammation that ultimately lead to protein damage, aggregation and degeneration of RPE. Specific degenerative findings for AMD are accumulation of intracellular lysosomal lipofuscin and extracellular drusens. In this review, we discuss thoroughly RPE-derived mechanisms in AMD pathology.
引用
收藏
页码：299 / 309
页数：11
相关论文
共 177 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein
    Akiyama, H
    Mohamedali, KA
    Silva, RLE
    Kachi, S
    Shen, JK
    Hatara, C
    Umeda, N
    Hackett, SF
    Aslam, S
    Krause, M
    Lai, H
    Rosenblum, MG
    Campochiaro, PA
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1543 - 1550
  • [3] Age-related maculopathy: pathogenetic features and new treatment modalities
    Algvere, PV
    Seregard, S
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (02): : 136 - 143
  • [4] Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies
    Ambati, J
    Ambati, BK
    Yoo, SH
    Ianchulev, S
    Adamis, AP
    [J]. SURVEY OF OPHTHALMOLOGY, 2003, 48 (03) : 257 - 293
  • [5] Anand R, 2000, OPHTHALMOLOGY, V107, P2224
  • [6] Perspective - A role for local inflammation in the formation of drusen in the aging eye
    Anderson, DH
    Mullins, RF
    Hageman, GS
    Johnson, LV
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (03) : 411 - 431
  • [7] Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: Implications for the process of drusen formation
    Anderson, DH
    Ozaki, S
    Nealon, M
    Neitz, J
    Mullins, RF
    Hageman, GS
    Johnson, LV
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (06) : 767 - 781
  • [8] Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)
    Arjamaa, Olli
    Nikinmaa, Mikko
    Salminen, Antero
    Kaarniranta, Kai
    [J]. AGEING RESEARCH REVIEWS, 2009, 8 (04) : 349 - 358
  • [9] Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
    Baird, PN
    Richardson, AJ
    Robman, LD
    Dimitrov, PN
    Tikellis, G
    McCarty, CA
    Guymer, RH
    [J]. HUMAN MUTATION, 2006, 27 (04) : 337 - 342
  • [10] Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential
    Barnstable, CJ
    Tombran-Tink, J
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2004, 23 (05) : 561 - 577
12345678910